Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 6c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q4 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $11.87 million versus the consensus estimate of $13.08 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• CIENA (CIEN) PT Lowered to $520 at Needham, 'We would be buyers on weakness'
• Crusoe Signs Roughly $13b Jane Street Deal For Cloud Computing - Bloomberg